VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 32 filers reported holding VERA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $370,485 | +105.2% | 27,023 | +140.3% | 0.00% | – |
| Q2 2023 | $180,514 | +188.3% | 11,247 | +39.4% | 0.00% | – |
| Q1 2023 | $62,623 | -82.7% | 8,070 | -56.8% | 0.00% | -100.0% |
| Q4 2022 | $361,787 | -7.5% | 18,697 | +2.0% | 0.00% | 0.0% |
| Q3 2022 | $391,000 | +54.5% | 18,335 | -1.2% | 0.00% | – |
| Q2 2022 | $253,000 | +84.7% | 18,554 | +217.2% | 0.00% | – |
| Q1 2022 | $137,000 | -5.5% | 5,850 | +8.0% | 0.00% | – |
| Q4 2021 | $145,000 | +119.7% | 5,416 | +41.9% | 0.00% | – |
| Q3 2021 | $66,000 | – | 3,817 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,960,231 | $57,280,470 | 18.66% |
| Kynam Capital Management, LP | 1,409,098 | $27,266,046 | 4.18% |
| Sofinnova Investments, Inc. | 3,181,442 | $61,560,903 | 3.65% |
| Octagon Capital Advisors LP | 665,156 | $12,870,769 | 2.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 281,257 | $5,428,260 | 1.68% |
| Vivo Capital, LLC | 400,666 | $7,753 | 0.89% |
| Eversept Partners, LP | 411,308 | $7,958,810 | 0.70% |
| Logos Global Management LP | 285,000 | $5,514,750 | 0.65% |
| Alphabet Inc. | 301,580 | $5,835,573 | 0.34% |
| CARNEGIE MELLON UNIVERSITY | 16,060 | $310,761 | 0.17% |